| 前收盘价格 | 68.24 |
| 收盘价格 | 67.98 |
| 成交量 | 433,177 |
| 平均成交量 (3个月) | 704,648 |
| 市值 | 3,031,497,216 |
| 价格/销量 (P/S) | 16.50 |
| 股市价格/股市净资产 (P/B) | 1.19 |
| 52周波幅 |
| 营业利益率 (TTM) | -482.59% |
| 稀释每股收益 (EPS TTM) | -59.59 |
| 季度收入增长率 (YOY) | 19.10% |
| 总债务/股东权益 (D/E MRQ) | 2.67% |
| 流动比率 (MRQ) | 9.70 |
| 营业现金流 (OCF TTM) | -464.88 M |
| 杠杆自由现金流 (LFCF TTM) | -236.88 M |
| 资产报酬率 (ROA TTM) | -11.98% |
| 股东权益报酬率 (ROE TTM) | -62.22% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Diagnostics & Research (US) | 混合的 | 看涨 |
| Diagnostics & Research (全球的) | 混合的 | 看涨 | |
| 股票 | GRAIL, Inc. | 混合的 | 看涨 |
AIStockmoo 评分
0.5
| 分析师共识 | NA |
| 内部交易活动 | NA |
| 价格波动 | 2.0 |
| 技术平均移动指标 | 0.0 |
| 技术振荡指标 | -0.5 |
| 平均 | 0.50 |
|
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service. |
|
| 部门 | Healthcare |
| 行业 | Diagnostics & Research |
| 投资方式 | Small Core |
| 内部持股比例 | 14.18% |
| 机构持股比例 | 66.50% |
该时间范围内无数据。
该时间范围内无数据。
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合